|
US4602705A
(en)
|
1981-11-09 |
1986-07-29 |
Lucas Industries Public Limited Company |
Flywheel mechanism for anti-skid braking systems
|
|
US5364773A
(en)
|
1991-03-07 |
1994-11-15 |
Virogenetics Corporation |
Genetically engineered vaccine strain
|
|
US4652639A
(en)
|
1982-05-06 |
1987-03-24 |
Amgen |
Manufacture and expression of structural genes
|
|
US4518584A
(en)
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
|
US6100064A
(en)
|
1984-04-06 |
2000-08-08 |
Chiron Corporation |
Secreted viral proteins useful for vaccines and diagnostics
|
|
US7815916B1
(en)
|
1984-08-22 |
2010-10-19 |
The United States Of America As Represented By The Secretary Of Health And Human Services |
Cloning and expression of HTLV-III DNA
|
|
US5032510A
(en)
|
1984-09-26 |
1991-07-16 |
Eli Lilly And Company |
Method for expression and secretion in bacillus
|
|
CA1341482C
(en)
|
1984-10-31 |
2005-05-10 |
Paul A. Luciw |
Process for preparing fragments of aids-associated retroviruses
|
|
WO1986003224A1
(en)
|
1984-11-29 |
1986-06-05 |
Scripps Clinic And Research Foundation |
Polypeptides and antibodies related to deglycosylated viral glycoproteins
|
|
EP0187041B1
(en)
|
1984-12-24 |
1996-05-15 |
Genentech, Inc. |
Fusions of AIDS-related polypeptides
|
|
NZ215867A
(en)
|
1985-04-19 |
1989-10-27 |
Hoffmann La Roche |
Aids envelope protein, dna vectors and method of production
|
|
DE3689941D1
(de)
|
1985-10-24 |
1994-08-04 |
Southwest Found Biomed Res |
Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
|
|
EP0242216A1
(en)
|
1986-04-16 |
1987-10-21 |
THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce |
Non-cytopathic clone of Human T-Cell Lymphotropic Virus type III
|
|
WO1988000471A1
(en)
|
1986-07-21 |
1988-01-28 |
Southwest Foundation For Biomedical Research |
Composition of matter and method of immunizing against viral causative agents of aids and arc
|
|
US4861707A
(en)
|
1987-02-02 |
1989-08-29 |
E. I. Du Pont De Nemours And Company |
Human immunodeficiency virus antigen
|
|
US5256767A
(en)
|
1987-06-10 |
1993-10-26 |
The Immune Response Corporation |
Retroviral antigens
|
|
IL86832A
(en)
|
1987-06-22 |
2002-09-12 |
Medeva Holdings Bv |
A recombinant DNA molecule containing a nucleotide sequence of part of the region encoding HBV pre-1s, an immunogenic particle containing multiple peptide monomers containing a pre-s1 epitope and pharmaceutical preparations containing it
|
|
US5637677A
(en)
|
1987-07-16 |
1997-06-10 |
The Trustees Of The University Of Pennsylvania |
Biologically active compounds and methods of constructing and using the same
|
|
US5128319A
(en)
|
1987-08-28 |
1992-07-07 |
Board Of Regents, The University Of Texas System |
Prophylaxis and therapy of acquired immunodeficiency syndrome
|
|
WO1989002277A2
(en)
|
1987-08-28 |
1989-03-23 |
Board Of Regents, The University Of Texas System |
Prophylaxis and therapy of acquired immunodeficiency syndrome
|
|
EP0347435A4
(en)
|
1987-09-04 |
1991-11-21 |
Biogen, Inc. |
Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins
|
|
US5879907A
(en)
|
1987-09-14 |
1999-03-09 |
Skandigen Ab |
Artificial gene coding for authentic human serum albumin, use thereof and method
|
|
PT88641B
(pt)
|
1987-10-02 |
1993-04-30 |
Genentech Inc |
Metodo para a preparacao de uma variante de adesao
|
|
IL87902A0
(en)
|
1987-10-08 |
1989-03-31 |
Dana Farber Cancer Inst Inc |
Soluble human cd4 fragments and applications thereof
|
|
US5683864A
(en)
|
1987-11-18 |
1997-11-04 |
Chiron Corporation |
Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
|
|
US5714596A
(en)
|
1987-11-18 |
1998-02-03 |
Chiron Corporation |
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
|
|
US5712088A
(en)
|
1987-11-18 |
1998-01-27 |
Chiron Corporation |
Methods for detecting Hepatitis C virus using polynucleotides specific for same
|
|
US5204259A
(en)
|
1988-05-06 |
1993-04-20 |
Pharmacia Genetic Engineering, Inc. |
Methods and systems for producing HIV antigens
|
|
CA1340748C
(en)
|
1988-07-13 |
1999-09-14 |
Stephen Oroszlan |
Synthetic hiv protease gene and method for its expression
|
|
ATE112687T1
(de)
|
1988-09-13 |
1994-10-15 |
Chiron Corp |
Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen.
|
|
AU640619B2
(en)
|
1988-10-03 |
1993-09-02 |
Repligen Corporation |
Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
|
|
CA2003383A1
(en)
|
1988-11-23 |
1990-05-23 |
Sushil G. Devare |
Synthetic dna derived recombinant hiv antigens
|
|
AU5184190A
(en)
|
1989-02-23 |
1990-09-26 |
University Of Ottawa |
Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine
|
|
US5082767A
(en)
|
1989-02-27 |
1992-01-21 |
Hatfield G Wesley |
Codon pair utilization
|
|
IL93682A
(en)
|
1989-03-16 |
1996-06-18 |
Yeda Res & Dev |
Polycyclic compounds with antigypical activity are used in the manufacture of medicines and pharmaceutical preparations containing them
|
|
WO1990011359A1
(en)
|
1989-03-20 |
1990-10-04 |
Whitehead Institute For Biomedical Research |
Intracellular method of inhibiting hiv in mammalian cells
|
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
|
DE69034168T3
(de)
|
1989-03-21 |
2013-04-11 |
Vical, Inc. |
Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
|
|
WO1990012094A1
(en)
|
1989-04-05 |
1990-10-18 |
The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce |
A clone of double-stranded rna virus and applications thereof
|
|
WO1990015141A2
(en)
|
1989-06-01 |
1990-12-13 |
Applied Biotechnology, Inc. |
Self-assembled, defective, non-self-propagating viral particles
|
|
US5130247A
(en)
|
1989-09-19 |
1992-07-14 |
Merck & Co., Inc. |
Expression of fusion protein of HIV envelope and HBsAG
|
|
CA2066607A1
(en)
|
1989-09-22 |
1991-03-23 |
Thomas Kieber-Emmons |
Peptides associated with the cd4 binding region of gp120 and their methods of use
|
|
DE69019291T2
(de)
|
1989-10-23 |
1995-09-21 |
F. Hoffmann-La Roche Ag, Basel |
Synthetische HTLV-I Hüll-Peptide.
|
|
JP2546544B2
(ja)
|
1989-10-27 |
1996-10-23 |
アーチ ディベラップメント コーポレイション |
免疫強化を促進するための方法と組成物
|
|
AU6965591A
(en)
|
1989-11-17 |
1991-06-13 |
Amgen, Inc. |
A method of detecting htlv-i antibodies in human body fluids
|
|
JPH05503629A
(ja)
|
1989-11-20 |
1993-06-17 |
オンコーゲン リミテッド パートナーシップ |
抗ウィルス剤及び免疫原として使用される、非複製組換え製レトロウィルス粒子
|
|
SE468168B
(sv)
|
1990-02-20 |
1992-11-16 |
Replico Medical Ab |
Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
|
|
IE910779A1
(en)
|
1990-03-09 |
1991-09-11 |
Chiron Corp |
PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
|
|
US5876724A
(en)
|
1990-03-19 |
1999-03-02 |
Institut Pasteur |
Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein
|
|
EP0449116B2
(en)
|
1990-03-21 |
2004-08-25 |
Geneart GmbH |
DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof
|
|
ATE125157T1
(de)
|
1990-04-03 |
1995-08-15 |
Genentech Inc |
Methoden und zusammensetzungen zur impfung gegen hiv.
|
|
JPH05506221A
(ja)
|
1990-04-03 |
1993-09-16 |
ジェネンテク,インコーポレイテッド |
Hivエンベロープポリペプチド
|
|
IL97985A0
(en)
|
1990-05-07 |
1992-06-21 |
North American Vaccine Inc |
Improved vaccine compositions
|
|
AP237A
(en)
|
1990-05-29 |
1993-04-29 |
Cedars Sinai Medical Center |
Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
|
|
WO1991019803A1
(en)
|
1990-06-19 |
1991-12-26 |
Applied Biotechnology, Incorporated |
Self assembled, defective, nonself-propagating viral particles
|
|
AU641554B2
(en)
|
1990-08-29 |
1993-09-23 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Novel peptide antigens and immunoassays, test kits and vaccines using the same
|
|
US5840313A
(en)
|
1990-09-27 |
1998-11-24 |
Syntello Vaccine Development Kb |
Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
|
|
EP0550516A1
(en)
|
1990-09-28 |
1993-07-14 |
Hospital For Joint Diseases |
Method for inhibiting the infectivity of human immunodeficiency virus
|
|
WO1992009690A2
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
|
IE920366A1
(en)
|
1991-02-04 |
1992-08-12 |
Univ Saskatchewan |
Vp6 encapsulated drug delivery
|
|
AU1643692A
(en)
|
1991-03-07 |
1992-10-06 |
Seragen, Inc. |
Use of cell surface receptor targeted molecules for the treatment of viral diseases
|
|
US6139843A
(en)
|
1991-04-02 |
2000-10-31 |
Albert Einstein College Of Medicine Of Yeshiva University |
Peptide compositions for the treatment of HIV
|
|
AU2412692A
(en)
|
1991-07-23 |
1993-02-23 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Novel peptide antigens and immunoassays, test kits and vaccines using the same
|
|
WO1994015621A1
(en)
|
1993-01-13 |
1994-07-21 |
Arsinur Burcoglu |
Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
|
|
KR100251823B1
(ko)
|
1991-08-22 |
2000-04-15 |
안도 고끼 |
사람 면역 결핍 바이러스(hiv) 감염의 면역치료용 모노클로날 항체
|
|
US5665569A
(en)
|
1991-08-22 |
1997-09-09 |
Nissin Shokuhin Kabushiki Kaisha |
HIV immunotherapeutics
|
|
WO1993006126A1
(en)
|
1991-09-13 |
1993-04-01 |
Chiron Corporation |
Immunoreactive hepatitis c virus polypeptide compositions
|
|
EP0613378A1
(en)
|
1991-10-28 |
1994-09-07 |
Institut Pasteur |
Induction of protection against viral infection by synergy between viral proteins and viral peptides
|
|
WO1993014789A1
(en)
|
1992-01-22 |
1993-08-05 |
New England Medical Center Hospitals, Inc. |
Pathogen-specific ctl therapy
|
|
US5174666A
(en)
|
1992-02-12 |
1992-12-29 |
Smith Corona Corporation |
Printing device having printwheel coupling means
|
|
US6174666B1
(en)
|
1992-03-27 |
2001-01-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of eliminating inhibitory/instability regions from mRNA
|
|
JP2001504572A
(ja)
|
1992-04-09 |
2001-04-03 |
アボツト・ラボラトリーズ |
Hiv抗原及びhiv抗体を検出するためのアッセイ
|
|
AU687736B2
(en)
|
1992-05-11 |
1998-03-05 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for inhibiting viral replication
|
|
US5663169A
(en)
|
1992-08-07 |
1997-09-02 |
Merck & Co., Inc. |
Benzoxazinones as inhibitors of HIV reverse transcriptase
|
|
DE4228458A1
(de)
|
1992-08-27 |
1994-06-01 |
Beiersdorf Ag |
Multicistronische Expressionseinheiten und deren Verwendung
|
|
US6004763A
(en)
|
1992-09-11 |
1999-12-21 |
Institut Pasteur |
Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
|
|
FR2695563B1
(fr)
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
|
CA2105629A1
(en)
|
1992-09-14 |
1994-03-15 |
Robert S. Becker |
Potentiation of immunogenic response
|
|
US5686078A
(en)
|
1992-09-14 |
1997-11-11 |
Connaught Laboratories, Inc. |
Primary and secondary immunization with different physio-chemical forms of antigen
|
|
DE69332744T2
(de)
|
1992-09-30 |
2004-01-15 |
Scripps Research Inst |
Humaner neutralisierender monoklonaler antikörper gegen den die immunschwäche beim menschen hervorringenden virus
|
|
US5652138A
(en)
|
1992-09-30 |
1997-07-29 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to human immunodeficiency virus
|
|
US5648267A
(en)
|
1992-11-13 |
1997-07-15 |
Idec Pharmaceuticals Corporation |
Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
|
|
US5304472A
(en)
|
1992-11-20 |
1994-04-19 |
Genentech, Inc. |
Method of controlling polypeptide production in bacterial cells
|
|
EP0672142B1
(en)
|
1992-12-04 |
2001-02-28 |
Medical Research Council |
Multivalent and multispecific binding proteins, their manufacture and use
|
|
WO1994016060A1
(en)
|
1993-01-11 |
1994-07-21 |
The Trustees Of The University Of Pennsylvania |
Mutants of hiv for supression of hiv infection
|
|
DE4400659C2
(de)
|
1993-01-16 |
1995-07-27 |
Manfred Dr Schawaller |
Verfahren zur Gewinnung nativer Domänen viraler Membranproteine, deren Verwendung, insbesondere als Impfstoff gegen HIV, sowie diese nativen Domänen viraler Membranproteine selbst
|
|
US5593972A
(en)
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
|
PT681483E
(pt)
|
1993-01-26 |
2005-11-30 |
Wyeth Corp |
Composicoes e metodos para distribuicao de material genetico
|
|
AU6235294A
(en)
|
1993-02-02 |
1994-08-29 |
Scripps Research Institute, The |
Methods for producing polypeptide binding sites
|
|
WO1994020640A1
(en)
|
1993-03-05 |
1994-09-15 |
Genelabs Technologies, Inc. |
Method for hiv quantitation
|
|
WO1994020141A1
(en)
|
1993-03-11 |
1994-09-15 |
The University Of Southern California |
Therapeutic strategies for immunoinfective cluster virus infections
|
|
US5869624A
(en)
|
1993-03-26 |
1999-02-09 |
Progenics Pharmaceuticals, Inc. |
HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof
|
|
JP4108118B2
(ja)
|
1993-03-26 |
2008-06-25 |
ジェン−プローブ・インコーポレイテッド |
ヒト・免疫不全ウイルス1型の検出
|
|
JPH08509606A
(ja)
|
1993-04-20 |
1996-10-15 |
ロビンソン,ウィリアム エス. |
細胞内感染因子に感染した個体を処置する方法および物質
|
|
US5419900A
(en)
|
1993-05-19 |
1995-05-30 |
The United States Of America As Represented By The Department Of Of Health And Human Services |
Immunologic enhancement with intermittent interleukin-2 therapy
|
|
NZ267838A
(en)
|
1993-06-07 |
1997-12-19 |
Genentech Inc |
Preparation of an hiv gp 120 subunit vaccine involving determining a neutralising epitope in the v2 and/or c4 domains
|
|
KR960703136A
(ko)
|
1993-06-09 |
1996-06-19 |
미첼 클레인 |
탠덤 합성 hiv-1 펩티드들
|
|
US5614413A
(en)
|
1993-07-01 |
1997-03-25 |
The Uab Research Foundation |
Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
|
|
CA2125344A1
(en)
|
1993-07-01 |
1995-01-02 |
Casey D. Morrow |
Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
|
|
JPH09501562A
(ja)
|
1993-07-19 |
1997-02-18 |
ジェン−プローブ・インコーポレイテッド |
ヒト・免疫不全ウイルスに対する活性を有するオリゴヌクレオチド
|
|
WO1995004818A1
(en)
|
1993-08-06 |
1995-02-16 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for inhibiting human immunodeficiency virus replication
|
|
US6261558B1
(en)
|
1993-10-19 |
2001-07-17 |
The Scripps Research Institute |
Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus
|
|
JPH09504296A
(ja)
|
1993-10-26 |
1997-04-28 |
シンテロ インコーポレイテッド |
Hiv粘膜感染の阻止
|
|
IL112820A0
(en)
|
1994-03-07 |
1995-05-26 |
Merck & Co Inc |
Coordinate in vivo gene expression
|
|
EP0750636A1
(en)
|
1994-03-14 |
1997-01-02 |
University Of Southern California |
Methods to diagnose and treat hiv-1 infection
|
|
WO1995027505A1
(en)
|
1994-04-12 |
1995-10-19 |
Biomira, Inc. |
Cellular immune response-specific antigens and uses therefor
|
|
ATE221786T1
(de)
|
1994-04-29 |
2002-08-15 |
Univ Duke |
Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus
|
|
WO1995033206A1
(en)
|
1994-05-31 |
1995-12-07 |
Abbott Laboratories |
Detection of different hiv genotypes utilizing a synthetic peptide-modified immunoassay
|
|
WO1995033835A1
(en)
|
1994-06-02 |
1995-12-14 |
Chiron Corporation |
Nucleic acid immunization using a virus-based infection/transfection system
|
|
US5733781A
(en)
|
1994-07-19 |
1998-03-31 |
Gen-Probe Incorporated |
Oligonucleotides and methods for inhibiting propagation of human immunodeficiency virus
|
|
US6291157B1
(en)
|
1998-02-23 |
2001-09-18 |
Connaught Laboratories Limited |
Antigenically-marked non-infectious retrovirus-like particles
|
|
US5955342A
(en)
|
1994-08-15 |
1999-09-21 |
Connaught Laboratories Limited |
Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
|
|
US6080408A
(en)
|
1994-08-22 |
2000-06-27 |
Connaught Laboratories Limited |
Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
|
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
US5795737A
(en)
|
1994-09-19 |
1998-08-18 |
The General Hospital Corporation |
High level expression of proteins
|
|
AU3593095A
(en)
|
1994-09-23 |
1996-04-09 |
Johns Hopkins University School Of Medicine, The |
Method of treatment of human immunodeficiency virus (hiv) infection
|
|
AU3876795A
(en)
|
1994-11-17 |
1996-06-17 |
Maxim Pharmaceuticals, Inc. |
Immunogens for stimulating mucosal immunity
|
|
US5550280A
(en)
|
1994-11-30 |
1996-08-27 |
Uniroyal Chemical Ltd./ Uniroyal Chemical Ltee |
Hindered aromatic ester compounds useful as anti-viral agents
|
|
JPH10512243A
(ja)
|
1994-12-30 |
1998-11-24 |
カイロン コーポレイション |
遺伝子送達ビヒクルの非外傷性投与
|
|
US6689761B1
(en)
|
1995-02-01 |
2004-02-10 |
Merck & Co., Inc. |
Combination therapy for HIV infection
|
|
FR2730411B1
(fr)
|
1995-02-14 |
1997-03-28 |
Centre Nat Rech Scient |
Association medicamenteuse utile pour la transfection et l'expression in vivo d'exogenes
|
|
EP0817854A2
(en)
|
1995-03-31 |
1998-01-14 |
Wolf, Hans, Prof. Dr. |
Antigen presentation system based on retrovirus-like particles
|
|
US5797870A
(en)
|
1995-06-07 |
1998-08-25 |
Indiana University Foundation |
Pericardial delivery of therapeutic and diagnostic agents
|
|
US6251405B1
(en)
|
1995-06-07 |
2001-06-26 |
Connaught Laboratories, Inc. |
Immunological combination compositions and methods
|
|
AU6483896A
(en)
|
1995-07-07 |
1997-02-10 |
The Texas A & M University System |
Nucleotide and amino acid sequence and uses thereof
|
|
WO1997011605A1
(en)
|
1995-09-28 |
1997-04-03 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Stimulation of cell-mediated immune responses by targeted particulate genetic immunization
|
|
AU1750497A
(en)
|
1996-01-17 |
1997-08-11 |
Progenics Pharmaceuticals, Inc. |
Compounds capable of inhibiting hiv-1 infection
|
|
CU22559A1
(es)
|
1996-01-17 |
1999-05-03 |
Ct Ingenieria Genetica Biotech |
Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
|
|
US5741492A
(en)
|
1996-01-23 |
1998-04-21 |
St. Jude Children's Research Hospital |
Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
|
|
US6087486A
(en)
|
1996-01-29 |
2000-07-11 |
The Trustees Of The University Of Pennsylvania |
Nucleotide sequences encoding vpr receptor protein
|
|
US6060587A
(en)
|
1996-01-29 |
2000-05-09 |
The Trustees Of The University Of Pennsylvania |
Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
|
|
US5649652A
(en)
|
1996-02-16 |
1997-07-22 |
Sackett; Eleanor L. |
Clothes hanger with storage hook
|
|
WO1997031115A2
(en)
*
|
1996-02-22 |
1997-08-28 |
Merck & Co., Inc. |
Synthetic hiv genes
|
|
US6451592B1
(en)
|
1996-04-05 |
2002-09-17 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
|
JP2000516445A
(ja)
|
1996-06-21 |
2000-12-12 |
メルク エンド カンパニー インコーポレーテッド |
合成遺伝子を含むワクチン
|
|
US5951975A
(en)
|
1996-06-28 |
1999-09-14 |
University Of Pittsburgh |
Induction of CTLs specific for natural antigens by cross priming immunization
|
|
WO1998008539A1
(en)
|
1996-08-26 |
1998-03-05 |
Chiron Corporation |
Postinfection human immunodeficiency virus (hiv) vaccination therapy
|
|
US6093800A
(en)
|
1996-09-06 |
2000-07-25 |
The Regents Of The University Of California |
E25a protein, methods for production and use thereof
|
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
|
US6139833A
(en)
|
1997-08-08 |
2000-10-31 |
Lexicon Genetics Incorporated |
Targeted gene discovery
|
|
US5830697A
(en)
|
1997-01-21 |
1998-11-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
P-glycoprotein mutant resistant to cyclosporin modulation
|
|
JP2001512308A
(ja)
*
|
1997-02-07 |
2001-08-21 |
メルク エンド カンパニー インコーポレーテッド |
合成hiv gag遺伝子
|
|
US5990091A
(en)
|
1997-03-12 |
1999-11-23 |
Virogenetics Corporation |
Vectors having enhanced expression, and methods of making and uses thereof
|
|
WO1998041536A1
(en)
|
1997-03-14 |
1998-09-24 |
President And Fellows Of Harvard College |
Glycosylation deficient siv and hiv envelope glycoproteins
|
|
CA2283740C
(en)
|
1997-03-14 |
2006-06-27 |
Idec Pharmaceuticals Corporation |
Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
|
|
CA2285058C
(en)
|
1997-03-24 |
2004-06-01 |
Evan W. Steeg |
Coincidence detection method, products and apparatus
|
|
AU754242B2
(en)
|
1997-04-28 |
2002-11-07 |
Arsinur Burcoglu |
Method of treating HIV infection and related secondary infections thereof
|
|
US5858675A
(en)
|
1997-05-13 |
1999-01-12 |
Incyte Pharmaceuticals, Inc. |
Double-stranded RNA-binding protein
|
|
US6099847A
(en)
|
1997-05-15 |
2000-08-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Chimeric Gag pseudovirions
|
|
AU8160298A
(en)
|
1997-06-23 |
1999-01-04 |
Emory University |
Human immunodeficiency viruses causing aids in a nonhuman primate
|
|
EP1002091B1
(en)
|
1997-07-09 |
2012-02-29 |
Coridon Pty Limited |
Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
|
|
EP1000177B1
(en)
|
1997-08-01 |
2007-04-25 |
Genetic Systems Corporation |
Synthetic antigens for the detection of antibodies having immunoreactivity against hiv virus
|
|
WO1999012416A1
(en)
|
1997-09-09 |
1999-03-18 |
The Trustees Of Columbia University In The City Of New York |
T-independent conjugate-vaccines
|
|
AU9496798A
(en)
|
1997-09-19 |
1999-04-05 |
Shire Laboratories, Inc. |
Solid solution beadlet
|
|
US5932442A
(en)
|
1997-09-23 |
1999-08-03 |
Incyte Pharmaceuticals, Inc. |
Human regulatory molecules
|
|
US5932445A
(en)
|
1997-11-07 |
1999-08-03 |
Incyte Pharmaceuticals, Inc. |
Signal peptide-containing proteins
|
|
FR2773156B1
(fr)
|
1997-12-26 |
2000-03-31 |
Biovacs Inc |
Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
|
|
EP1054991A1
(en)
|
1998-02-11 |
2000-11-29 |
Genvec, Inc. |
Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
|
|
GB9803351D0
(en)
*
|
1998-02-17 |
1998-04-15 |
Oxford Biomedica Ltd |
Anti-viral vectors
|
|
EP1078052A2
(en)
|
1998-04-14 |
2001-02-28 |
Chiron Corporation |
Noncloning technique for expressing a gene of interest
|
|
CA2328180A1
(en)
|
1998-04-14 |
1999-10-21 |
Merck & Co., Inc. |
Needleless administration of polynucleotide formulations
|
|
DE69929432T2
(de)
|
1998-04-22 |
2006-09-28 |
Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville |
Erhöhung der immunantworten bei genetischer immunisierung durch verwendung eines chemokins
|
|
US6090388A
(en)
|
1998-06-20 |
2000-07-18 |
United Biomedical Inc. |
Peptide composition for prevention and treatment of HIV infection and immune disorders
|
|
FR2780069B1
(fr)
|
1998-06-23 |
2002-06-28 |
Inst Nat Sante Rech Med |
Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications
|
|
EP1102788A4
(en)
|
1998-08-03 |
2002-08-28 |
Univ Montana |
PREVENTION AND TREATMENT OF VIRAL PATHOLOGY
|
|
AU6139699A
(en)
*
|
1998-09-11 |
2000-04-03 |
Children's Medical Center Corporation |
Packaging cell lines for hiv-derived retroviral vector particles
|
|
AU5980899A
(en)
|
1998-09-25 |
2000-04-17 |
Smithkline Beecham Biologicals (Sa) |
Novel compounds
|
|
AU6425999A
(en)
|
1998-10-09 |
2000-05-01 |
Dynavax Technologies Corporation |
Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens
|
|
US6489542B1
(en)
|
1998-11-04 |
2002-12-03 |
Monsanto Technology Llc |
Methods for transforming plants to express Cry2Ab δ-endotoxins targeted to the plastids
|
|
WO2000039304A2
(en)
|
1998-12-31 |
2000-07-06 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|
|
EP1980617A1
(en)
|
1998-12-31 |
2008-10-15 |
Novartis Vaccines and Diagnostics, Inc. |
Improved expression of HIV polypeptides and production of virus-like particles
|
|
PT1141315E
(pt)
|
1998-12-31 |
2008-05-05 |
Novartis Vaccines & Diagnostic |
Polipéptidos do envelope (env) de hiv modificados
|
|
WO2000044926A1
(en)
|
1999-01-27 |
2000-08-03 |
Stratagene |
High level expression of a heterologous protein having rare codons
|
|
AU778809B2
(en)
|
1999-03-29 |
2004-12-23 |
Statens Serum Institut |
Method for producing a nucleotide sequence construct with optimised codons for an HIV genetic vaccine based on primary, early HIV isolate and synthetic envelope BX08 constructs
|
|
IL146090A0
(en)
|
1999-04-26 |
2002-07-25 |
Leuven K U Res & Dev |
A synthetic gene for expression of a retroviral protein with wild type activity in eukaryotic cells
|
|
CA2371766A1
(en)
|
1999-05-03 |
2000-11-09 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
|
BR0010323A
(pt)
|
1999-05-06 |
2002-01-08 |
Immune Response Corp Inc |
Composições imunogênicas, kit e método de confecção da mesma para uso na imunização de um mamìfero
|
|
ATE418340T1
(de)
|
1999-05-06 |
2009-01-15 |
Univ Wake Forest |
Zusammensetzungen und methoden zur identifikation von antigenen, die eine immunantwort hervorrufen
|
|
US6420545B1
(en)
|
1999-05-24 |
2002-07-16 |
The Trustees Of The University Of Pennsylvania |
CD4-independent HIV envelope proteins as vaccines and therapeutics
|
|
US6280989B1
(en)
|
1999-06-17 |
2001-08-28 |
Dmitri Kapitonov |
Sialyltransferases
|
|
EP1200622A4
(en)
|
1999-07-06 |
2004-12-22 |
Merck & Co Inc |
HIV VACCINE FROM AN ADENOVIRUS CARRYING THE GAG GENE
|
|
US7479285B1
(en)
|
1999-08-19 |
2009-01-20 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
|
CA2392010A1
(en)
|
1999-08-27 |
2001-03-08 |
Regents Of The University Of California |
Use of lentiviral vectors for antigen presentation in dendritic cells
|
|
CA2384271A1
(en)
|
1999-09-17 |
2001-03-22 |
Joseph G. Sodroski |
Stabilized soluble glycoprotein trimers
|
|
CA2384828A1
(en)
|
1999-09-21 |
2001-03-29 |
Zivko Nikolov |
Methods for producing recombinant proteins
|
|
JP2003511420A
(ja)
|
1999-10-13 |
2003-03-25 |
カイロン コーポレイション |
タンパク質から細胞性免疫応答を得る方法
|
|
WO2001029225A1
(en)
|
1999-10-21 |
2001-04-26 |
Panorama Research, Inc. |
A general method for optimizing the expression of heterologous proteins
|
|
US6316253B1
(en)
|
1999-11-01 |
2001-11-13 |
Chiron Corporation |
Expression vectors, transfection systems, and method of use thereof
|
|
CA2391084A1
(en)
|
1999-11-13 |
2001-05-25 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
High order nucleic acid based structures
|
|
US20030049251A1
(en)
|
1999-12-08 |
2003-03-13 |
Barbas Carlos F. |
Methods and compositions useful for inhibiting ccr5-dependent infection of cells by hiv-1
|
|
EP1242441A4
(en)
|
1999-12-17 |
2004-04-14 |
Merck & Co Inc |
CODON OPTIMIZED HIV-1 NEF AND MODIFIED HIV-1 NEF EXPRESSING POLYNUCLEOTID VACCINE
|
|
WO2001045748A1
(en)
|
1999-12-22 |
2001-06-28 |
Merck & Co., Inc. |
Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol
|
|
WO2001047955A2
(en)
|
1999-12-23 |
2001-07-05 |
Medical Research Council |
Improvements in or relating to immune responses to hiv
|
|
ES2329648T3
(es)
|
1999-12-23 |
2009-11-30 |
The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services |
Clones moleculares con genes mutados gag/pol de vih, gag de vis y env de vis.
|
|
AU2001233063A1
(en)
|
2000-01-31 |
2001-08-07 |
Aaron Diamond Aids Research Center |
Vaccination of hiv infected persons following highly active antiretroviral therapy
|
|
AU783005B2
(en)
|
2000-01-31 |
2005-09-15 |
Smithkline Beecham Biologicals (Sa) |
Novel use
|
|
AU2001238501A1
(en)
|
2000-02-16 |
2001-08-27 |
Bechtel Bwxt Idaho, Llc |
Selective destruction of cells infected with human immunodeficiency virus
|
|
AU4529401A
(en)
|
2000-02-18 |
2001-08-27 |
Univ Washington |
Aids ancestral viruses and vaccines
|
|
ATE320792T1
(de)
|
2000-09-28 |
2006-04-15 |
Chiron Corp |
Mikropartikel zur verabreichung von heterologen nukleinsäure
|
|
AU2002320314A1
(en)
|
2001-07-05 |
2003-01-21 |
Chiron, Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|